Favipiravir Generics - Manufacturers & Suppliers
Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
| Product/Composition:- | Favipiravir |
|---|---|
| Strength:- | 200 mg, 400 mg, 600 mg |
| Form:- | Tablet |
| Reference Brands:- | Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Favipiravir, an antiviral used for mild to moderate COVID-19, is approved in countries like India, Japan, and Russia, under brands such as Fabiflu, Avigan, and Avifavir. Though not approved in the US or EU, it's widely sourced across Asia, LATAM, and MENA. PharmaB2B platforms connect buyers with trusted Favipiravir exporters and manufacturers, offering bulk supply, global reach, and regulatory-compliant sourcing.
Favipiravir is a broad-spectrum antiviral used in the treatment of mild to moderate COVID-19 in countries like India, Japan, Russia, and Bangladesh. Commonly available in 200 mg and 400 mg tablets, it is marketed under leading brands such as Fabiflu, Avigan, and Avifavir. While not approved in the US or EU, Favipiravir remains in demand across Asia, the Middle East, and Latin America. Global PharmaB2B platforms connect verified Favipiravir suppliers, manufacturers, and exporters, ensuring regulatory-compliant sourcing, competitive pricing, and bulk availability. Partner with trusted B2B pharmaceutical networks for efficient distribution and international trade.